Results from these studies also provide new therapeutic opportunities where methylation therapy alone or in combination with various therapeutic strategies currently under development to target genes which we have identified like uPA and its receptor to elicit strong synergistic effects to significantly reduce morbidity and mortality in cancer patients in general and those with OS in particular. Here, PLAU is linked to cancer.